Somerset Trust’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,984
Closed -$235K 97
2019
Q4
$235K Sell
6,984
-2,799
-29% -$101K 0.12% 100
2019
Q3
$366K Sell
9,783
-3,004
-23% -$115K 0.19% 96
2019
Q2
$558K Sell
12,787
-358
-3% -$15.3K 0.29% 87
2019
Q1
$561K Sell
13,145
-38
-0.3% -$1.7K 0.3% 89
2018
Q4
$590K Sell
13,183
-6
-0% -$314 0.34% 83
2018
Q3
$903K Sell
13,189
-9
-0.1% -$579 0.45% 77
2018
Q2
$756K Sell
13,198
-234
-2% -$12.4K 0.41% 81
2018
Q1
$619K Buy
13,432
+76
+0.6% +$3.61K 0.32% 95
2017
Q4
$617K Sell
13,356
-77
-0.6% -$3.54K 0.31% 95
2017
Q3
$605K Buy
13,433
+815
+6% +$34.8K 0.32% 96
2017
Q2
$495K Buy
12,618
+90
+0.7% +$3.4K 0.27% 108
2017
Q1
$477K Buy
12,528
+12,450
+15,962% +$485K 0.27% 109
2016
Q4
$3K Buy
+78
New +$2.79K ﹤0.01% 144

Other funds holding AVNS

Somerset Trust's AVNS Position: Q1 2020 in Review

Somerset Trust sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 6,984 shares — an estimated $235K sold.

Somerset Trust first reported a position in AVNS in Q4 2016 and held it in 13 quarters. The position peaked at $903K in Q3 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Somerset Trust reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • Somerset Trust sold 6,984 Avanos Medical shares in Q1 2020, an estimated $235K.
  • Somerset Trust first reported a position in Avanos Medical in Q4 2016 and held it in 13 quarters.
  • Somerset Trust's Avanos Medical position peaked at $903K in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Somerset Trust's 13F filing for Q1 2020, filed 20 Apr 2020.